TrialThe Journal of biological chemistry2012

α2β1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK).

Dalila Naci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.